All Pharma News
NPS Pharma`s Parathyroid Hormone Receives Supplemental Approval in US

NPS Pharma`s Parathyroid Hormone Receives Supplemental Approval in US
FDA
07 Apr 2022
Share Share
NPS Pharm`s Natpara (Parathyroid Hormone) Receives Approval in US

NPS Pharm`s Natpara (Parathyroid Hormone) Receives Approval in US
FDA
10 Jun 2020
Share Share
NPS Pharms` Biological Parathyroid Hormone Receives Supplemental Approval in US

NPS Pharms` Biological Parathyroid Hormone Receives Supplemental Approval in US
FDA
01 Oct 2018
Share Share
Shire CEO Ornskov racks up $21M in pay, a fivefold leap from 2014

Shire CEO Ornskov racks up $21M in pay, a fivefold leap from 2014
Tracy Staton FIERCE PHARMA
31 Mar 2016
Share Share
With Baxalta in hand, Shire`s not looking to buy. But sell? Maybe

With Baxalta in hand, Shire`s not looking to buy. But sell? Maybe
Carly Helfand FIERCE PHARMA
11 Feb 2016
Share Share
Pharma M&A shoots up to $159B for first half, but prices could dampen the mood

Pharma M&A shoots up to $159B for first half, but prices could dampen the mood
Carly Helfand FIERCE PHARMA
17 Jul 2015
Share Share
What’s Real in Rare Disease

What’s Real in Rare Disease
William Looney PHARM EXEC.COM
18 Apr 2015
Share Share
Careful, European drugmakers. Fitch says M&A may be a bit too heated

Careful, European drugmakers. Fitch says M&A may be a bit too heated
Tracy Staton FIERCE PHARMA
17 Apr 2015
Share Share
Shire`s Lialda, Gattex are hedge funder`s latest patent targets

Shire`s Lialda, Gattex are hedge funder`s latest patent targets
Tracy Staton FIERCE PHARMA
07 Apr 2015
Share Share
EXCLUSIVE: Shire (SHPGY) Buyout of BioMarin (BMRN)

EXCLUSIVE: Shire (SHPGY) Buyout of BioMarin (BMRN) "Seems Obvious," Source Close to the Deal Tells BioSpace (DHX)
Riley McDermid BIOSPACE
31 Mar 2015
Share Share